{"result": {"id": "8b141103-5ae2-4141-a82e-d08d423d410e", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>中华心血管病杂志（网络版）<|>ORGANIZATION<|>The online version of the Chinese Journal of Cardiovascular Diseases publishing research and guidelines)\n##\n(\"entity\"<|>中国乡村医药<|>ORGANIZATION<|>A Chinese journal focusing on rural medical care and policies)\n##\n(\"entity\"<|>中国循环杂志<|>ORGANIZATION<|>A Chinese medical journal publishing research on circulatory system diseases)\n##\n(\"entity\"<|>中国动脉硬化杂志<|>ORGANIZATION<|>A Chinese journal specializing in research on arteriosclerosis)\n##\n(\"entity\"<|>中华全科医师杂志<|>ORGANIZATION<|>A Chinese journal for general practitioners publishing clinical research)\n##\n(\"entity\"<|>现代实用医学<|>ORGANIZATION<|>A Chinese journal publishing practical medical research and case studies)\n##\n(\"entity\"<|>PAN L<|>PERSON<|>Researcher studying prevalence of dyslipidemia among Chinese adults)\n##\n(\"entity\"<|>YANG ZH<|>PERSON<|>Researcher studying prevalence of dyslipidemia among Chinese adults)\n##\n(\"entity\"<|>WU Y<|>PERSON<|>Researcher studying prevalence of dyslipidemia among Chinese adults)\n##\n(\"entity\"<|>ZHAO SP<|>PERSON<|>Researcher studying prevalence of dyslipidemia in patients treated with lipid-lowering agents)\n##\n(\"entity\"<|>WANG YJ<|>PERSON<|>Researcher studying prevalence of dyslipidemia in patients treated with lipid-lowering agents)\n##\n(\"entity\"<|>MU YM<|>PERSON<|>Researcher studying prevalence of dyslipidemia in patients treated with lipid-lowering agents)\n##\n(\"entity\"<|>AL COCER L<|>PERSON<|>Researcher studying hypertension as a public health problem in Mexico)\n##\n(\"entity\"<|>áLVAREZ-LóPEZ H<|>PERSON<|>Researcher studying hypertension as a public health problem in Mexico)\n##\n(\"entity\"<|>BOR RAYO-SáNCHEZ GB<|>PERSON<|>Researcher studying hypertension as a public health problem in Mexico)\n##\n(\"entity\"<|>ZHANG X<|>PERSON<|>Researcher studying combined effects of hypertension and dyslipidemia on left ventricular hypertrophy)\n##\n(\"entity\"<|>LI G<|>PERSON<|>Researcher studying combined effects of hypertension and dyslipidemia on left ventricular hypertrophy)\n##\n(\"entity\"<|>SHI C<|>PERSON<|>Researcher studying combined effects of hypertension and dyslipidemia on left ventricular hypertrophy)\n##\n(\"entity\"<|>HU HW<|>PERSON<|>Researcher studying China's tiered healthcare system reforms)\n##\n(\"entity\"<|>LIANG HL<|>PERSON<|>Researcher studying China's tiered healthcare system reforms)\n##\n(\"entity\"<|>WANG HF<|>PERSON<|>Researcher studying China's tiered healthcare system reforms)\n##\n(\"entity\"<|>SUN Y<|>PERSON<|>Researcher studying village doctor-led interventions for blood pressure control)\n##\n(\"entity\"<|>MU J<|>PERSON<|>Researcher studying village doctor-led interventions for blood pressure control)\n##\n(\"entity\"<|>WANG DW<|>PERSON<|>Researcher studying village doctor-led interventions for blood pressure control)\n##\n(\"entity\"<|>谢远玲<|>PERSON<|>Researcher contributing to medical studies in China)\n##\n(\"relationship\"<|>中华心血管病杂志（网络版）<|>中华心血管病杂志<|>Online and print versions of the same medical journal<|>9)\n##\n(\"relationship\"<|>PAN L<|>YANG ZH<|>Co-authors of dyslipidemia prevalence study<|>6)\n##\n(\"relationship\"<|>PAN L<|>WU Y<|>Co-authors of dyslipidemia prevalence study<|>6)\n##\n(\"relationship\"<|>ZHAO SP<|>WANG YJ<|>Co-authors of dyslipidemia treatment study<|>6)\n##\n(\"relationship\"<|>ZHAO SP<|>MU YM<|>Co-authors of dyslipidemia treatment study<|>6)\n##\n(\"relationship\"<|>AL COCER L<|>áLVAREZ-LóPEZ H<|>Co-authors of hypertension research<|>6)\n##\n(\"relationship\"<|>AL COCER L<|>BOR RAYO-SáNCHEZ GB<|>Co-authors of hypertension research<|>6)\n##\n(\"relationship\"<|>ZHANG X<|>LI G<|>Co-authors of hypertension/dyslipidemia research<|>6)\n##\n(\"relationship\"<|>ZHANG X<|>SHI C<|>Co-authors of hypertension/dyslipidemia research<|>6)\n##\n(\"relationship\"<|>HU HW<|>LIANG HL<|>Co-authors of healthcare reform study<|>6)\n##\n(\"relationship\"<|>HU HW<|>WANG HF<|>Co-authors of healthcare reform study<|>6)\n##\n(\"relationship\"<|>SUN Y<|>MU J<|>Co-authors of blood pressure intervention study<|>6)\n##\n(\"relationship\"<|>SUN Y<|>WANG DW<|>Co-authors of blood pressure intervention study<|>6)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752165768, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 1239, "prompt_tokens": 3985, "total_tokens": 5224, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3904}, "prompt_cache_hit_tokens": 3904, "prompt_cache_miss_tokens": 81}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 专家共识（2023 版）［J］. 中华心血管病   杂志（网络版），2023，6（1）：1-11.\n［3］  中国血脂管理指南修订联合专家委员会 . 中国血脂管理指南 （2023 年）［J］. 中华心血管病杂志，2023，51（3）：221-255.\n［4］ 牟燕，刘岩，孙帝力 .“互联网 +”与基层医疗卫生机构信息化 建设［J］. 中华医学图书情报杂志，2017，26（4）：8-11.\n［5］  国务院办公厅 . 国务院办公厅关于推进分级诊疗制度建设的指 导意见［J］. 中国乡村医药，2015，22（20）：86-88.\n［6］ PAN L，YANG ZH，WU Y， et al. The prevalence， awareness，treatment and control of dyslipidemia among adults in China［J］ . Atherosclerosis，2016，248：2-9.\n［7］  李苏宁， 张林峰， 王馨， 等 .2012—2015 年我国≥35 岁人群\n血脂异常状况调查［J］. 中国循环杂志，2019，34（7）：681- 687.\n［8］ ZHAO SP，WANG YJ，MU YM， et al. Prevalence of dyslipidaemia in patients treated with lipid-lowering\nagents in China：results of the DYSlipidemia International Study（DYSIS）［J］. Atherosclerosis ，2014，235（2）： 463-469.\n［9］  中华医学会心血管病学分会，中华心血管病杂志编辑委员会 . 血 管紧张素转换酶抑制剂在心血管病中应用中国专家共识［J］. 中华心血管病杂志，2007，35（2）：97-106.\n［10］ AL COCER L ，áLVAREZ-L óPEZ H，BOR RAYO- SáNCHEZ GB，et al. Hypertension as a persistent public health problem.A position paper from Alliance for a\n\n\n\n14    \n\n\n中国合理用药探索\n\n\nCHINESE JOURNAL OF RATIONAL DRUG USE\n\n\n标准与讨论 \n\n\n\nHealthy Heart，Mexico［J］. Ann Clin Hypertens，2019， 3（1）：9-30.\n［11］ 翁春艳，唐晓鸿，袁洪，等 . 高血压合并高脂血症对血管早期 病变的影响［J］. 中国动脉硬化杂志，2012，20（1）：52-56.\n［12］ ZHANG X，LI G，SHI C，et al. Combined superposition effect \tof hypertension and dyslipidemia on left ventricular hypertrophy ［J］.Animal Model Exp Med，2022，5（3）：227-238.\n［13］ HU HW，LIANG HL，WANG HF. Longitudinal study of the earliest pilot of tiered healthcare system reforms in China：will the new type of chronic disease management be effective?［J］. SocSciMed，2021，285：114284.\n［14］ SUN Y，MU J，WANG DW， et al. A village doctor- led multifaceted intervention for blood pressure control in rural China：an open，cluster randomised trial［J］. Lancet ，2022，399（10339）：1964-1975.\n［15］ 唐国宝，杨叔禹 . 厦门市“三师共管”慢性非传染性疾病分级诊 疗模式的实践与效果探讨［J］. 中华全科医师杂志，2016，15\n（2）：94-97.\n［16］ 张静，陈佳蕾，张焕军 . 社区综合干预模式对血脂异常患者的 管理效果分析［J］. 现代实用医学，2015，27（11）：1438- 1441.\n［17］ 谢远玲，\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>中华心血管病杂志<|>ORGANIZATION<|>A Chinese medical journal publishing research and guidelines on cardiovascular diseases)\n##\n(\"entity\"<|>中国血脂管理指南修订联合专家委员会<|>ORGANIZATION<|>A joint expert committee responsible for revising China's guidelines on blood lipid management)\n##\n(\"entity\"<|>中华医学图书情报杂志<|>ORGANIZATION<|>A Chinese journal focusing on medical library and information science)\n##\n(\"entity\"<|>国务院办公厅<|>ORGANIZATION<|>The General Office of the State Council of China, issuing policies and guidelines)\n##\n(\"entity\"<|>中华医学会心血管病学分会<|>ORGANIZATION<|>The Cardiovascular Branch of the Chinese Medical Association, involved in creating expert consensus on cardiovascular diseases)\n##\n(\"entity\"<|>中华心血管病杂志编辑委员会<|>ORGANIZATION<|>The editorial board of the Chinese Journal of Cardiovascular Diseases)\n##\n(\"entity\"<|>Alliance for a Healthy Heart, Mexico<|>ORGANIZATION<|>A Mexican organization focused on addressing hypertension as a public health problem)\n##\n(\"entity\"<|>牟燕<|>PERSON<|>A researcher contributing to studies on internet-based healthcare and primary care informatization)\n##\n(\"entity\"<|>刘岩<|>PERSON<|>A researcher contributing to studies on internet-based healthcare and primary care informatization)\n##\n(\"entity\"<|>孙帝力<|>PERSON<|>A researcher contributing to studies on internet-based healthcare and primary care informatization)\n##\n(\"entity\"<|>李苏宁<|>PERSON<|>A researcher involved in surveys on dyslipidemia among adults in China)\n##\n(\"entity\"<|>张林峰<|>PERSON<|>A researcher involved in surveys on dyslipidemia among adults in China)\n##\n(\"entity\"<|>王馨<|>PERSON<|>A researcher involved in surveys on dyslipidemia among adults in China)\n##\n(\"entity\"<|>翁春艳<|>PERSON<|>A researcher studying the impact of hypertension combined with dyslipidemia on vascular lesions)\n##\n(\"entity\"<|>唐晓鸿<|>PERSON<|>A researcher studying the impact of hypertension combined with dyslipidemia on vascular lesions)\n##\n(\"entity\"<|>袁洪<|>PERSON<|>A researcher studying the impact of hypertension combined with dyslipidemia on vascular lesions)\n##\n(\"entity\"<|>唐国宝<|>PERSON<|>A researcher involved in the practice and evaluation of tiered healthcare system reforms in Xiamen)\n##\n(\"entity\"<|>杨叔禹<|>PERSON<|>A researcher involved in the practice and evaluation of tiered healthcare system reforms in Xiamen)\n##\n(\"entity\"<|>张静<|>PERSON<|>A researcher analyzing the effects of community-based intervention models on dyslipidemia patients)\n##\n(\"entity\"<|>陈佳蕾<|>PERSON<|>A researcher analyzing the effects of community-based intervention models on dyslipidemia patients)\n##\n(\"entity\"<|>张焕军<|>PERSON<|>A researcher analyzing the effects of community-based intervention models on dyslipidemia patients)\n##\n(\"entity\"<|>厦门市<|>GEO<|>A city in China implementing tiered healthcare system reforms for chronic diseases)\n##\n(\"entity\"<|>中国血脂管理指南（2023年）<|>EVENT<|>The publication of China's updated guidelines on blood lipid management in 2023)\n##\n(\"entity\"<|>分级诊疗制度建设<|>EVENT<|>The implementation of a tiered healthcare system in China to improve chronic disease management)\n##\n(\"relationship\"<|>中国血脂管理指南修订联合专家委员会<|>中华心血管病杂志<|>The committee published the 2023 guidelines in the journal<|>8)\n##\n(\"relationship\"<|>中华医学会心血管病学分会<|>中华心血管病杂志编辑委员会<|>Both are involved in publishing expert consensus on cardiovascular diseases<|>7)\n##\n(\"relationship\"<|>牟燕<|>刘岩<|>Co-authors of a study on internet-based healthcare and primary care informatization<|>6)\n##\n(\"relationship\"<|>牟燕<|>孙帝力<|>Co-authors of a study on internet-based healthcare and primary care informatization<|>6)\n##\n(\"relationship\"<|>李苏宁<|>张林峰<|>Co-authors of a survey on dyslipidemia among adults in China<|>6)\n##\n(\"relationship\"<|>李苏宁<|>王馨<|>Co-authors of a survey on dyslipidemia among adults in China<|>6)\n##\n(\"relationship\"<|>翁春艳<|>唐晓鸿<|>Co-authors of a study on hypertension and dyslipidemia<|>6)\n##\n(\"relationship\"<|>翁春艳<|>袁洪<|>Co-authors of a study on hypertension and dyslipidemia<|>6)\n##\n(\"relationship\"<|>唐国宝<|>杨叔禹<|>Co-authors of a study on tiered healthcare system reforms in Xiamen<|>6)\n##\n(\"relationship\"<|>张静<|>陈佳蕾<|>Co-authors of a study on community-based interventions for dyslipidemia<|>6)\n##\n(\"relationship\"<|>张静<|>张焕军<|>Co-authors of a study on community-based interventions for dyslipidemia<|>6)\n##\n(\"relationship\"<|>国务院办公厅<|>分级诊疗制度建设<|>The State Council issued guidelines to promote the tiered healthcare system<|>7)\n##\n(\"relationship\"<|>厦门市<|>分级诊疗制度建设<|>Xiamen implemented a tiered healthcare system for chronic disease management<|>7)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_d0a6dbb3bd10bd66ffb1f2b426a034bcfeb901fc29a9476363ecfffc715ad236_v2"}